Atrys Health, S.A. (BME:ATRY)
Spain
· Delayed Price · Currency is EUR 2.830
-0.025 (-0.88%)
Apr 29, 2026, 11:31 AM CET
Atrys Health Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -100.3 | -31.77 | -45.59 | -23.15 | -23.26 | Upgrade
|
| Depreciation & Amortization | 21.84 | 23.81 | 23.21 | 25.22 | 16.7 | Upgrade
|
| Other Amortization | 5.38 | 5.24 | 6.47 | 5.12 | 4.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | 78.74 | 18.69 | 6.18 | 6.64 | 1.5 | Upgrade
|
| Other Operating Activities | -6.98 | -6.33 | 16.56 | -11.16 | 5.65 | Upgrade
|
| Change in Accounts Receivable | -2.08 | -7.36 | 0.36 | 0.5 | -2.74 | Upgrade
|
| Change in Inventory | -0.79 | -0.02 | -0.46 | -0.3 | -0.12 | Upgrade
|
| Change in Accounts Payable | 4.03 | 2.8 | 0.56 | -1.99 | 4.98 | Upgrade
|
| Change in Other Net Operating Assets | -1.4 | -2.05 | -1.57 | -11.95 | -2.1 | Upgrade
|
| Operating Cash Flow | -1.56 | 3 | 5.7 | -15.43 | 4.69 | Upgrade
|
| Operating Cash Flow Growth | - | -47.41% | - | - | - | Upgrade
|
| Capital Expenditures | -6.49 | -4.25 | -6.25 | -6.77 | -4.22 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.24 | - | - | 18.19 | Upgrade
|
| Cash Acquisitions | - | - | -24.08 | -75.81 | -10.82 | Upgrade
|
| Divestitures | - | - | 39.72 | 14 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -6.03 | -8.89 | -6.9 | -8.39 | -4.34 | Upgrade
|
| Investment in Securities | -0.07 | -0.06 | -2.09 | -3.61 | -1.25 | Upgrade
|
| Investing Cash Flow | -12.59 | -12.95 | 0.4 | -80.59 | -2.45 | Upgrade
|
| Long-Term Debt Issued | 31.75 | 29.37 | 18.18 | 51.9 | 142.92 | Upgrade
|
| Long-Term Debt Repaid | -20.43 | -40.85 | -17.06 | -39.6 | -128.71 | Upgrade
|
| Net Debt Issued (Repaid) | 11.32 | -11.48 | 1.11 | 12.3 | 14.2 | Upgrade
|
| Issuance of Common Stock | - | - | 0.29 | 82.48 | - | Upgrade
|
| Repurchase of Common Stock | -0.04 | -0.03 | - | - | -0.12 | Upgrade
|
| Financing Cash Flow | 11.28 | -11.51 | 1.4 | 94.77 | 14.08 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | 0.04 | 0.42 | 1.32 | Upgrade
|
| Net Cash Flow | -2.87 | -21.46 | 7.53 | -0.83 | 17.65 | Upgrade
|
| Free Cash Flow | -8.05 | -1.25 | -0.55 | -22.2 | 0.47 | Upgrade
|
| Free Cash Flow Margin | -5.58% | -0.93% | -0.27% | -13.60% | 0.38% | Upgrade
|
| Free Cash Flow Per Share | -0.11 | -0.02 | -0.01 | -0.33 | 0.01 | Upgrade
|
| Cash Interest Paid | 19.08 | 21.24 | 25.31 | 15.22 | 9.97 | Upgrade
|
| Cash Income Tax Paid | 1.44 | -0.71 | 2.21 | 2.48 | 1.09 | Upgrade
|
| Levered Free Cash Flow | -129.51 | -7.19 | -28.29 | 21.48 | -5.09 | Upgrade
|
| Unlevered Free Cash Flow | -117.62 | 6.92 | -7.64 | 30.56 | 1.81 | Upgrade
|
| Change in Working Capital | -0.24 | -6.63 | -1.12 | -13.74 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.